Alprazolam is a potent, short-acting benzodiazepine that impacts the central nervous system to produce a calming effect. It is mostly used for the treatment of anxiety and panic disorders.
Increase in geriatric population prone to depression and surge in prevalence of anxiety disorders, including phobias and generalized anxiety disorders, drive the Alprazolam powder market. Furthermore, the fast paced and stressful lifestyle leading to depression fuels the market growth. In addition, R&D activities on Alprazolam are anticipated to create new opportunities during the forecast period. However, stringent government regulations and adverse drug effects, such as drug addiction, hamper the growth. For instance, according to the Drug Abuse Warning Network (DAWN) report, the estimated number of drug-related visits to hospital emergency departments has increased from 57,419 visits in 2005 to 124,902 visits in 2010. Moreover, the gray market of Alprazolam restricts the market growth. For instance, in 2016, 9 people were killed in 3 months in Florida due to fake Xanaz pill (Alprazolam drug).
The Alprazolam powder market is segmented on the basis of application, end user, and geography. Based on application, it is divided into panic disorders, anxiety, depression, and insomnia. Based on end user, it is classified into research institutes, pharmaceutical companies, and others (hospitals and clinics). Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
- The study provides an in-depth analysis of the global Alprazolam powder market, with current trends and future estimations to elucidate the investment pockets.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of different segments facilitates to understand various products of the market.
- Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.
Alprazolam Powder Market Key Segments:
- Panic Disorders
By End User
- Research Institutes
- Pharmaceutical Companies
- Others (Hospitals and Clinics)
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia-Pacific
- Latin America
- Middle East
List of Players Profiled in the Report
- Pfizer Inc.
- Roche Holding AG
- Terrace Pharmaceuticals Ltd.
- Torrent Pharmaceuticals Ltd.
- Lupin Limited
- Unicure (India) Pvt. Ltd.
- Zydus Cadila Pharmaceuticals Ltd.
- Cipla Limited
- Abbott Healthcare Pvt. Ltd.